Hidden Heart Disease: Understanding INOCA and ANOCA
The INOCA/ANOCA tool is an educational resource designed to raise awareness of ischemia and angina that occur without obstructive coronary artery disease — conditions that are frequently missed despite significant symptoms and risk. It helps patients and providers recognize that a "normal" angiogram does not rule out heart disease, and highlights key symptoms, red flags and advanced diagnostic options such as coronary flow reserve and vasospasm testing. The tool emphasizes the disproportionate impact on women and the long delays many patients face before receiving an accurate diagnosis. Ultimately, it supports earlier recognition, appropriate testing and mechanism-specific treatment to improve outcomes and quality of life.
Implementing Lipid-Lowering Therapeutics in Your Clinical Practice: A Practical Guide for the Nurse Practitioner
The AANP Clinical Resource Tool for Lipid-Lowering Therapeutics empowers NPs with practical, evidence-based strategies to optimize cholesterol management and reduce cardiovascular risk. Designed as a quick reference guide, it highlights guideline-directed statin and nonstatin therapies; clinical pearls for improving adherence; and tips for overcoming common challenges such as side effects and insurance barriers. With actionable insights and patient-centered approaches, this resource equips NPs to confidently implement lipid-lowering therapies and improve long-term outcomes in their practice.
This activity is supported by educational grant funding provided by Amgen and Novartis.
Kidney Decline: Sounding the Alarm on the Silent Killer
Chronic kidney disease (CKD) affects more than 35 million Americans, yet many individuals remain unaware of their condition until it has progressed to advanced stages. Early recognition and timely intervention are critical to slowing disease progression and improving patient outcomes.
This clinical reference handout provides a concise, evidence-informed reference designed to support NPs in clinical practice. The resource highlights:
- Key risk factors and conditions associated with CKD
- Early signs and symptoms that may signal kidney decline
- CKD staging using glomerular filtration rate (GFR) and albuminuria
- Guidance on assessment, management and referral to kidney specialty care
- Considerations for timely transplant evaluation and referral
By supporting earlier identification and action, this resource helps clinicians address kidney disease before it reaches advanced stages.
This content was developed independently by American Association of Nurse Practitioners and supported by a healthcare contribution from Sanofi. AANP is an independent, non-profit organization representing healthcare providers and does not endorse or promote any specific commercial entities, products, services, or treatments.
Novel and Emerging Pharmacotherapies for Hypertension
This Clinical Resource Tool on Novel and Emerging Pharmacotherapies for Hypertension equips NPs with practical, evidence-based guidance to address one of the most prevalent and undertreated cardiovascular risk factors in the United States. Designed as a quick clinical reference, it highlights current guideline-directed management strategies, risk stratification approaches and key considerations for identifying and treating resistant hypertension — along with insights into emerging therapies. By combining clinical pearls with actionable treatment information, this resource supports NPs in optimizing hypertension management and improving long-term cardiovascular outcomes for their patients.
AANP originally developed this tool using funds from an independent medical education grant from AstraZeneca. Updates provided by AANP 10.6.26 (1280)
Patient Education Tools and Resources
Type 2 Diabetes and Kidney Health
This practical and informational handout has been created to facilitate shared decision-making conversations between the NP and their patients about type 2 diabetes (T2D) and CKD. The checklist format enables users to easily keep track of information like recent kidney and diabetes lab tests, blood pressure readings, CKD stage and kidney-protective medications. In order to optimize kidney health, an individualized plan of care — incorporating lifestyle changes, treatments and referrals — is included.
This activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company.
AANP Community
Engage, Learn, Network and Progress Practice in Cardiology
The AANP Cardiology Community offers a unique opportunity to interactively collaborate with colleagues who share an interest or clinical expertise in cardiology. As a community member, you’ll have access to a cutting-edge, online forum where you can engage in discussions, document sharing and knowledge exchange with fellow NPs. Come learn, share and help progress the development of theory and practice in cardiology.
Join the Cardiology Community
Cardiology Community Member Login
External Resources
Conveniently Curated Information From Other Top Sources
There are many resources available for both patients and providers. Some are listed below for your convenience. Inclusion of these links does not imply AANP endorsement.
Centers for Disease Control and Prevention (CDC) Resources
Additional Resources